The goal of the proposed research is to better understand partitioning of energy input and the efficiency of energy utilization in the isolated, supported rabbit left ventricle (LV). In the first portion of the proposed work, we will study a new approach to partition VO(2) into that-used for crossbridge cycling and that used for other purposes by using the drug 2,3-butanedione monoxime (BDM). At relatively low concentration, this drug selectively inhibits crossbridge cycling. The relationship between VO: and pressure-time integral as low-dose BDM is administered will be employed to estimate force-independent VO: [the VO: used for (excitation-contraction coupling + resting metabolism)]. Force-dependent VO:, or that used for crossbridge cycling, equals total V02 minus force-independent VO:. To calculate efficiency, pressure-volume area (PVA) will be used as an expression of total energy output of the contractile machinery. Efficiency is thus PVA + force-dependent V02. Using this approach, the relation between force-independent V02 and LV volume will be determined, as will the influence of load on efficiency. In the second portion of the proposed work, the effect on VO: partitioning and contractile efficiency of three positive inotropic interventions will be assessed. The interventions are designed to have differing effects on crossbridge cycling rate. In the last portion of the proposal, this approach will be applied to several models of chronic hypertrophic stress, including hyper- and hypothyroidism and chronic pressure overload due to renal hypertension. The models are designed to produce variations in both myosin isoenzyme distribution and the architecture/geometry of the LV. The latter work constitutes a preliminary attempt to understand whether chronic hypertrophic stress alters V02 partitioning and efficiency In the isolated, supported LV in a fashion which Is analogous to previously demonstrated alterations in isolated muscle.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL028001-10
Application #
3858966
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Peterson, J N; Nassar, R; Anderson, P A et al. (2001) Altered cross-bridge characteristics following haemodynamic overload in rabbit hearts expressing V3 myosin. J Physiol 536:569-82
Peterson, J N; Alpert, N R (1998) Cross-bridge dynamics in the contracting heart. Adv Exp Med Biol 453:117-23;discussion 123-4
Alpert, N R; Mulieri, L A (1997) Human heart failure: determinants of ventricular dysfunction. Adv Exp Med Biol 430:97-108
Peterson, J N; Alpert, N R (1996) Molecular motor mechanics in the contracting heart. V1 versus V3 myosin heavy chain. Ann N Y Acad Sci 793:54-63
VanBuren, P; Harris, D E; Alpert, N R et al. (1995) Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circ Res 77:439-44
Haeberle, J R (1994) Calponin decreases the rate of cross-bridge cycling and increases maximum force production by smooth muscle myosin in an in vitro motility assay. J Biol Chem 269:12424-31
Zarain-Herzberg, A; Marques, J; Sukovich, D et al. (1994) Thyroid hormone receptor modulates the expression of the rabbit cardiac sarco (endo) plasmic reticulum Ca(2+)-ATPase gene. J Biol Chem 269:1460-7
Laporte, R; Haeberle, J R; Laher, I (1994) Phorbol ester-induced potentiation of myogenic tone is not associated with increases in Ca2+ influx, myoplasmic free Ca2+ concentration, or 20-kDa myosin light chain phosphorylation. J Mol Cell Cardiol 26:297-302
Hemric, M E; Tracy, P B; Haeberle, J R (1994) Caldesmon enhances the binding of myosin to the cytoskeleton during platelet activation. J Biol Chem 269:4125-8
Fisher, S A; Periasamy, M (1994) Collagen synthesis inhibitors disrupt embryonic cardiocyte myofibrillogenesis and alter the expression of cardiac specific genes in vitro. J Mol Cell Cardiol 26:721-31

Showing the most recent 10 out of 32 publications